Young Alethia 4

What Happened Alethia Young, a director of Pacira BioSciences, received equity awards on June 10, 2026: 6,405 restricted stock units (RSUs) and 10,891 derivative awards (stock options). Both awards were granted at $0.00 (reported value $0) and are contingent on continued service; the RSUs convert to one share each at vesting and the options vest and become exercisable on June 10, 2027.

Key Details

• Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (filed within the typical two-business-day window).
• Grants: 6,405 RSUs (award, $0.00 per share) and 10,891 derivative awards (options, $0.00 reported).
• Vesting: RSUs vest on June 10, 2027 (each RSU = right to one share). Options vest and become exercisable on June 10, 2027. Both subject to continuous service through the vesting date (see footnotes F1, F2).
• Transaction code: A = Award/Grant. No cash purchase or sale occurred.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context These were service‑conditioned equity grants, not open‑market purchases or sales. RSUs will convert to shares only if vesting conditions are met; options will only be exercisable after vesting. Such awards are routine compensation for directors and do not by themselves indicate buying or selling sentiment.